News

腸内マイクロバイオームへの薬物投与

Nature Biotechnology 33, 3 doi: 10.1038/nbt.3161

Using conventional drug discovery and novel synthetic biology approaches, some investigators and companies are mining our resident microbes and their metabolites for targets in small-molecule drug programs. Ken Garber reports.

目次へ戻る

プライバシーマーク制度